Pharmaceutical

STAT+: Uninsured rate hits ‘record low’ — right before ...

New CDC survey data show 7.7% of Americans had no health insurance as of this pa...

STAT+: Vertex non-opioid therapy reduced pain in mid-st...

A pair of Vertex clinical trials showed an experimental non-opioid drug reduced ...

STAT+: With new acquisitions, Humana and CVS hope to tu...

Humana and CVS Health are working to funnel their health plan members into their...

ProMED, an early warning system on disease outbreaks, a...

The early warning disease network that alerted the world to the original SARS ou...

‘Shocking’ heat waves persist through August as federal...

An already record-setting summer heat wave will continue through August and will...

CDC recommends RSV monoclonal antibody for infants, hig...

A panel of advisers to the CDC unanimously voted Thursday to recommend wide use ...

Stress in childhood linked to physical and cognitive pr...

Adults ages 50-97 who had experienced violence as children were 80% more likely ...

Listen: Biotech layoffs, eye drug drama, & gene therapy...

Can biotech startups survive a downturn? Is Covid-19 a good business? And when d...

‘Ancient DNA’ tools and 23andMe database uncover Africa...

Combining “ancient DNA” tools with 23andMe's data identified thousands of people...

STAT+: Alnylam reports growth in sales of rare disease ...

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare dise...

STAT+: Study proposing microbiome-based cancer diagnost...

Computational biologist Steven Salzberg says the problems with a Nature paper ab...

STAT+: Vertex faces renewed calls to widen access to it...

"It is clear Vertex’s pricing strategy represents a formidable barrier to univer...

STAT+: White House drug shortage task force held rare i...

A new White House task force held a rare in-person meeting Friday to brainstorm ...

STAT+: Pharmalittle: Patients brace for insurance decis...

Insurers have started aggressively cracking down on weight loss medications, whi...

TytoCare raises $49 million to build out AI-enhanced ch...

TytoCare has raised $49 million to build out AI-enhanced chronic care. The Serie...

STAT+: Startup Celsius cuts 75% of staff ahead of first...

Celsius Therapeutics, a biotech company based in Cambridge, Mass., has laid off ...